NCT04873739

Brief Summary

The aim of thie study to assess tear film parameters such as tear meniscus height (TMH), tear meniscus area (TMA), and tear meniscus depth (TMD). In addition, corneal pachymetry and epithelial thickness maps in SLE patients and compared to healthy subjects of similar age and gender.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jul 2020

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2020

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2021

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 30, 2021

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

April 30, 2021

Completed
5 days until next milestone

First Posted

Study publicly available on registry

May 5, 2021

Completed
Last Updated

February 3, 2022

Status Verified

June 1, 2021

Enrollment Period

7 months

First QC Date

April 30, 2021

Last Update Submit

January 20, 2022

Conditions

Keywords

anterior segment optical coherence tomographytear filmdry eyesystemic lupus erythematous

Outcome Measures

Primary Outcomes (2)

  • Measurement of Tear meniscus

    to measure lower tear meniscus height and area and depth with AS-OCT and comparing results between 3 groups; SLE patients with dry eye, SLE patients without dry eye and normal subjects.

    3 months

  • Measurement of corneal structural changes

    To measure corneal Thickness, epithelial thickness and stromal thickness using AS-OCT comparing results between 3 groups; SLE patients with dry eye, SLE patients without dry eye and normal subjects.

    3 months

Study Arms (3)

20 patients SLE with dry eye

Anterior segment OCT for SLE patients with dry eye

Diagnostic Test: Anterior Segment OCT

30 patients SLE without dry eye

Anterior segment OCT for SLE patients without dry eye

Diagnostic Test: Anterior Segment OCT

50 normal subjects as control group of similar age and gender

Anterior segment OCT for normal subjects

Diagnostic Test: Anterior Segment OCT

Interventions

Anterior Segment OCTDIAGNOSTIC_TEST

AS-OCT for SLE patients with dry eye, SLE patients without dry eye and compare them with normal subjects.

20 patients SLE with dry eye30 patients SLE without dry eye50 normal subjects as control group of similar age and gender

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Residents of Minia Governorate diagnosed with SLE and healthy one

You may qualify if:

  • Age ≥18 years old..
  • Patients with SLE diagnosed by a rheumatologist with no ocular involvement upon clinical examination

You may not qualify if:

  • \. Patients with history of intraocular surgery as cataract surgery ,retinal detachment surgery, anti-glucoma surgery.
  • \. Patients with history of any corneal refractive surgery as LASIK, PRK. 3. Patients with significant media opacity as corneal opacity, cataract. 4. Patients with ocular diseases as glaucoma, uveitis. 5. Patients with any retinal affection as pathological myopia, macular hole, age related macular degeneration and retinal vascular occlusion.
  • \. Patients with systemic diseases as diabetes mellitus, hypertension, abnormal kidney function.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Minia university hospital

Minya, Egypt

Location

Related Publications (8)

  • Palejwala NV, Walia HS, Yeh S. Ocular manifestations of systemic lupus erythematosus: a review of the literature. Autoimmune Dis. 2012;2012:290898. doi: 10.1155/2012/290898. Epub 2012 Jul 2.

    PMID: 22811887BACKGROUND
  • Rees F, Doherty M, Grainge MJ, Lanyon P, Zhang W. The worldwide incidence and prevalence of systemic lupus erythematosus: a systematic review of epidemiological studies. Rheumatology (Oxford). 2017 Nov 1;56(11):1945-1961. doi: 10.1093/rheumatology/kex260.

    PMID: 28968809BACKGROUND
  • Yu C, Gershwin ME, Chang C. Diagnostic criteria for systemic lupus erythematosus: a critical review. J Autoimmun. 2014 Feb-Mar;48-49:10-3. doi: 10.1016/j.jaut.2014.01.004. Epub 2014 Jan 21.

    PMID: 24461385BACKGROUND
  • Read RW. Clinical mini-review: systemic lupus erythematosus and the eye. Ocul Immunol Inflamm. 2004 Jun;12(2):87-99. doi: 10.1080/09273940490895308.

    PMID: 15512979BACKGROUND
  • Benitez del Castillo JM, Wasfy MA, Fernandez C, Garcia-Sanchez J. An in vivo confocal masked study on corneal epithelium and subbasal nerves in patients with dry eye. Invest Ophthalmol Vis Sci. 2004 Sep;45(9):3030-5. doi: 10.1167/iovs.04-0251.

    PMID: 15326117BACKGROUND
  • Kanellopoulos AJ, Aslanides IM, Asimellis G. Correlation between epithelial thickness in normal corneas, untreated ectatic corneas, and ectatic corneas previously treated with CXL; is overall epithelial thickness a very early ectasia prognostic factor? Clin Ophthalmol. 2012;6:789-800. doi: 10.2147/OPTH.S31524. Epub 2012 May 23.

    PMID: 22701079BACKGROUND
  • Nguyen P, Huang D, Li Y, Sadda SR, Ramos S, Pappuru RR, Yiu SC. Correlation between optical coherence tomography-derived assessments of lower tear meniscus parameters and clinical features of dry eye disease. Cornea. 2012 Jun;31(6):680-5. doi: 10.1097/ICO.0b013e3182261577.

    PMID: 22378111BACKGROUND
  • Li Y, Tan O, Brass R, Weiss JL, Huang D. Corneal epithelial thickness mapping by Fourier-domain optical coherence tomography in normal and keratoconic eyes. Ophthalmology. 2012 Dec;119(12):2425-33. doi: 10.1016/j.ophtha.2012.06.023. Epub 2012 Aug 20.

    PMID: 22917888BACKGROUND

MeSH Terms

Conditions

Lupus Erythematosus, SystemicDry Eye Syndromes

Condition Hierarchy (Ancestors)

Connective Tissue DiseasesSkin and Connective Tissue DiseasesAutoimmune DiseasesImmune System DiseasesLacrimal Apparatus DiseasesEye Diseases

Study Officials

  • Mohamed Abdelkader, Doctor

    Minia University Hospital

    PRINCIPAL INVESTIGATOR
  • Mohamed Salah, Doctor

    Minia University Hospital

    STUDY DIRECTOR
  • Mohamed Hamid, Doctor

    Minia University Hospital

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 30, 2021

First Posted

May 5, 2021

Study Start

July 1, 2020

Primary Completion

February 1, 2021

Study Completion

March 30, 2021

Last Updated

February 3, 2022

Record last verified: 2021-06

Locations